CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-17 | Soffer Gad Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −4,145 | 40,076 | ||
| 2015-08-17 | Soffer Gad Chief Operating Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −2,778 | 37,222 | ||
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +9,615 | 40,199 | ||
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +1,291 | $25.15 | $32K | 41,490 |
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +469 | $11.00 | $5K | 41,959 |
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Sale | −7,829 | $46.19 | $362K | 34,130 |
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Restricted Stock Units | −9,615 | 74,519 | ||
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,291 | 40,042 | ||
| 2015-08-17 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −469 | 14,531 | ||
| 2015-08-17 | Haqq Christopher Chief Medical Officer | Exercise or conversion | +829 | 247,494 | ||
| 2015-08-17 | Haqq Christopher Chief Medical Officer | Sale | −1,304 | $45.75 | $60K | 246,190 |
| 2015-08-17 | Haqq Christopher Chief Medical Officer | Sale | −300 | $46.58 | $14K | 245,890 |
| 2015-08-17 | Haqq Christopher Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −829 | 8,015 | ||
| 2015-08-17 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion | +5,907 | 41,532 | ||
| 2015-08-17 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,907 | 57,108 | ||
| 2015-08-17 | Fust Matthew K Director | Exercise or conversion | +1,603 | 9,081 | ||
| 2015-08-17 | Fust Matthew K Director | Exercise or conversion · Restricted Stock Units | −1,603 | 16,559 | ||
| 2015-08-03 | Turner Heather D VP, General Counsel & Sec. | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2015-07-31 | Ciechanover Isaac E. Chief Executive Officer | Sale | −900 | $55.41 | $50K | 381,882 |
| 2015-07-31 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,100 | $56.25 | $62K | 380,782 |
Page 63 of 71 · 1,403 trades